Archives
Cy3 Goat Anti-Human IgG (H+L) Antibody: Signal Amplificat...
Cy3 Goat Anti-Human IgG (H+L) Antibody: Signal Amplification for Immunoassays
Overview: Principle and Setup of Cy3 Conjugated Secondary Antibody
The Cy3 Goat Anti-Human IgG (H+L) Antibody from APExBIO is a polyclonal goat anti-human IgG secondary antibody conjugated with the Cy3 fluorophore (excitation 552 nm, emission 565 nm). Designed for unparalleled sensitivity, it detects human immunoglobulins (IgG, both heavy and light chains) in a variety of immunological assays. This reagent is affinity-purified and validated for applications including immunofluorescence assay (ICC/IF), immunohistochemistry (IHC-Fr, IHC-P), flow cytometry, and ELISA. Cy3’s bright, photostable signal paired with the antibody’s high affinity enables robust signal amplification—a critical advantage when detecting low-abundance targets or performing multiplexed analyses.
In the context of advancing infectious disease research—for example, in the mapping of neutralizing antibody responses against orthopoxviruses as seen in the recent Nature EMBO Molecular Medicine study—the need for sensitive, specific, and reproducible human immunoglobulin detection is paramount. As researchers design and screen monoclonal and bispecific antibodies for therapeutic applications, the Cy3 Goat Anti-Human IgG (H+L) Antibody provides a reliable solution for quantifying antibody-antigen interactions, characterizing immune responses, and validating therapeutic efficacy.
Step-by-Step Workflow: Protocol Enhancements for Maximum Performance
1. Sample Preparation and Blocking
- ICC/IF: Fix cells with 4% paraformaldehyde (10-15 min), permeabilize using 0.1-0.2% Triton X-100, and block with 1-5% BSA for 30-60 min at room temperature.
- IHC (Frozen/Paraffin): For paraffin sections, deparaffinize and rehydrate, perform antigen retrieval (citrate buffer pH 6.0), and block endogenous peroxidase with 0.3% H2O2 if necessary. Block nonspecific sites as above.
- Flow Cytometry: Wash cells in PBS with 1% BSA and block Fc receptors as needed to minimize background.
- ELISA: Coat plates with antigen, block with 1% BSA or 5% non-fat milk in PBS.
2. Primary Antibody Incubation
- Incubate samples with the human IgG primary antibody (monoclonal or polyclonal) at the recommended dilution. For rare or low-abundance targets, optimize incubation time (typically 1 h at room temperature or overnight at 4°C) for maximal binding.
3. Secondary Antibody (Cy3 Goat Anti-Human IgG) Incubation
- Dilute the Cy3 Goat Anti-Human IgG (H+L) Antibody (SKU: K1208) 1:200–1:1000 in blocking buffer, depending on application and detection system sensitivity.
- Incubate for 30–60 min at room temperature, protected from light.
- Wash thoroughly (3–5 times) with PBS or PBST to remove unbound antibody and reduce background.
4. Detection and Imaging
- ICC/IF/IHC: Visualize with fluorescence microscopy using Cy3 filter sets. Quantitative imaging is enabled by Cy3’s high quantum yield.
- Flow Cytometry: Analyze using a 561 nm laser and a 575/26 nm (or similar) emission filter. Cy3 signal enables clear separation from FITC and Alexa Fluor 488 channels.
- ELISA: Read fluorescence with a plate reader (excitation/emission: 550/570 nm) or, if using a peroxidase-conjugated amplification, follow the relevant detection protocol.
5. Data Analysis
- Normalize fluorescence intensity to background and reference controls.
- For quantitative assays (ELISA, flow), generate standard curves to enable precise IgG quantification.
For detailed guidance and troubleshooting across these workflows, the Practical Solutions with Cy3 Goat Anti-Human IgG (H+L) Antibody article provides scenario-driven insights to maximize sensitivity and reproducibility in human immunoglobulin detection.
Advanced Applications and Comparative Advantages
Multiplex Immunoassays and Translational Research
The Cy3 Goat Anti-Human IgG (H+L) Antibody’s high sensitivity and spectral compatibility make it ideal for multiplexed immunofluorescence panels. It can be used alongside FITC, Alexa Fluor 488, Cy5, and other fluorophores for simultaneous detection of multiple analytes. For instance, in the recent orthopoxvirus antibody characterization study, such advanced multiplexing would enable researchers to dissect the breadth and specificity of anti-M1R and anti-B6R antibody responses in a single assay, accelerating epitope mapping and therapeutic candidate screening.
Signal Amplification and Quantitative Precision
Compared to directly labeled primary antibodies, using a Cy3 conjugated secondary antibody amplifies signal by allowing multiple secondary antibodies to bind each primary, yielding up to 10-fold higher fluorescence intensity (see supporting data). This amplification is critical for detecting low-abundance human IgG in clinical samples, such as serum from patients with early-stage infection or low immunogenicity.
Compatibility with Diverse Sample Types
Whether working with cultured cells, tissue sections, whole blood, or plasma, the Cy3 Goat Anti-Human IgG (H+L) Antibody demonstrates broad compatibility and low cross-reactivity. Its polyclonal nature ensures recognition of multiple epitopes, enhancing detection robustness across IgG subclasses. This versatility is highlighted in both translational research and diagnostics, where sample quality and composition can vary considerably.
Reproducibility and Vendor Reliability
The reagent is supplied at 1 mg/mL in a stabilizing buffer with 23% glycerol, ensuring long-term stability (12 months at -20°C). APExBIO’s rigorous immunoaffinity purification and QC processes minimize batch-to-batch variability—an essential consideration for longitudinal studies and clinical assay standardization.
For a broader perspective on multiplexing advantages and the antibody’s role in translational innovation, Translating Immunofluorescence into Innovation expands on mechanistic rationale and clinical relevance, complementing the workflow guidance above.
Troubleshooting and Optimization Tips
- Background Fluorescence: Ensure stringent blocking (1–5% BSA or normal goat serum) and thorough washing. Reduce secondary antibody concentration if background persists.
- Weak Signal: Verify primary antibody quality and concentration. Extend incubation times or increase secondary antibody dilution within validated ranges (up to 1:200).
- Photobleaching: Minimize light exposure throughout the workflow. Mount slides with anti-fade reagents and store samples protected from light.
- Cross-reactivity: Confirm species specificity; include isotype and no-primary controls. The antibody’s H+L specificity covers all human IgG subclasses but may detect denatured IgG in harsh processing conditions.
- Flow Cytometry Compensation: Properly compensate for Cy3 spectral overlap with PE or other nearby fluorophores. Acquire single-stained controls and adjust voltages as needed.
- Storage and Handling: Aliquot upon arrival and store at -20°C for long-term use. Avoid freeze-thaw cycles to preserve activity and fluorescence.
For a comprehensive troubleshooting checklist and protocol optimization strategies, the resource High-Sensitivity Cy3 Goat Anti-Human IgG (H+L) Antibody extends these insights with quantified performance metrics and use-case scenarios.
Future Outlook: Empowering Next-Generation Immunoassays
As translational research accelerates and the demand for precise, multiplexed immunodetection grows, the Cy3 Goat Anti-Human IgG (H+L) Antibody stands out as a foundational tool. From antibody discovery (as in orthopoxvirus therapeutic development) to clinical diagnostics and vaccine monitoring, its robust signal amplification, reproducibility, and versatility will continue to drive innovations in immunoassay design.
Emerging trends such as spatially resolved proteomics, digital pathology, and high-dimensional flow cytometry will further leverage the strengths of Cy3-based fluorescent secondary antibodies. As the landscape of human immunoglobulin detection evolves, APExBIO remains a trusted partner, ensuring researchers have access to high-quality, validated reagents for every stage of discovery and development.